Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes

J Van Paassen, JS Vos, EM Hoekstra, KMI Neumann… - Critical Care, 2020 - Springer
Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of …

Impact of corticosteroids in coronavirus disease 2019 outcomes: systematic review and meta-analysis

EJ Cano, XF Fuentes, CC Campioli, JC O'Horo… - Chest, 2021 - Elsevier
Background Since its appearance in late 2019, infections caused by severe acute
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …

Characteristics of viral shedding time in SARS-CoV-2 infections: a systematic review and meta-analysis

D Yan, X Zhang, C Chen, D Jiang, X Liu… - Frontiers in public …, 2021 - frontiersin.org
Background: The viral shedding time (VST) of SARS-CoV-2 mainly determines its
transmission and duration of infectiousness. However, it was heterogeneous in the existing …

[HTML][HTML] Beyond a zero-sum game: how does the impact of COVID-19 vary by gender?

R Morgan, P Baker, DM Griffith, SL Klein… - Frontiers in …, 2021 - frontiersin.org
Epidemics and pandemics, like COVID-19, are not gender neutral. Much of the current work
on gender, sex, and COVID-19, however, has seemed implicitly or explicitly to be attempting …

Time to recovery and its predictors among adults hospitalized with COVID-19: a prospective cohort study in Ethiopia

SA Abrahim, M Tessema, A Defar, A Hussen, E Ejeta… - PloS one, 2020 - journals.plos.org
Background Various factors may determine the duration of viral shedding (the time from
infection to viral RNA-negative conversion or recovery) in COVID-19 patients …

[HTML][HTML] Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19

C Bennasrallah, I Zemni, W Dhouib, H Sriha… - International journal of …, 2021 - Elsevier
Objectives The aim of this study was to identify the factors influencing the delay in severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA negative conversion …

Emerging insights into the pathophysiology of multisystem inflammatory syndrome associated with COVID-19 in children

J Lin, AS Harahsheh, G Raghuveer, S Jain… - Canadian Journal of …, 2023 - Elsevier
Multisystem inflammatory syndrome in children (MIS-C) has emerged as a rare delayed
hyperinflammatory response to SARS-CoV-2 infection and causes severe morbidity in the …

Viral clearance course of COVID-19 outbreaks

SM Samrah, AH Al-Mistarehi, T Kewan… - Journal of …, 2021 - Taylor & Francis
Background Coronavirus disease 2019 (COVID-19) viral course and behavior remain
unpredictable. This study describes incubation time and viral clearance of COVID-19 …

Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study

Y Li, Q Meng, X Rao, B Wang, X Zhang, F Dong, T Yu… - Critical Care, 2020 - Springer
Background Corticoid therapy has been recommended in the treatment of critically ill
patients with COVID-19, yet its efficacy is currently still under evaluation. We investigated the …

Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis

Y Okita, T Morita, A Kumanogoh - Inflammation and regeneration, 2022 - Springer
Background The duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) RNA positivity will be important to prevent the spread of coronavirus disease 2019 …